Why the study?
Does the newly synthesized pyrazole derivative LQFM-21 reduce blood pressure in spontaneously hypertensive rats?
Population
Spontaneously hypertensive rats (SHR) and isolated aortic rings from SHR
Design
Preclinical
Follow-up
15 days
Authors
Loading...
Provides preclinical support for LQFM-21 in hypertension; leaves open translation to human efficacy and safety.
Does the newly synthesized pyrazole derivative LQFM-21 reduce blood pressure in spontaneously hypertensive rats?
The newly synthesized pyrazole derivative LQFM-21 lowers blood pressure and induces vasodilation in hypertensive rats via the NO/cGMP pathway.
Trindade et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: